Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,006 | 19,760 | 19,529 | 19,964 | 22,985 |
| Receivables | 23,526 | 29,925 | 29,403 | 29,882 | 28,937 |
| Inventories | 12,141 | 13,193 | 13,001 | 12,966 | 11,995 |
| Other current assets | 1,121 | 1,003 | 1,333 | 749 | 0 |
| TOTAL | $61,891 | $71,130 | $71,371 | $70,599 | $71,079 |
| Non-Current Assets | |||||
| PPE Net | 693 | 967 | 1,127 | 1,722 | 1,815 |
| Intangibles | 52,453 | 54,082 | 55,711 | 57,341 | 58,970 |
| Other Non-Current Assets | 3,058 | 2,684 | 3,040 | 3,226 | 4,599 |
| TOTAL | $56,204 | $57,733 | $59,878 | $62,289 | $65,384 |
| Total Assets | $118,095 | $128,863 | $131,249 | $132,888 | $136,463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,252 | 16,716 | 1,065 | 1,277 | 1,648 |
| Accounts payable and accrued liabilities | 10,314 | 10,475 | 10,473 | 14,466 | 13,478 |
| Accrued Expenses | 38,143 | 44,091 | 43,413 | 40,730 | 46,799 |
| Other current liabilities | 8,962 | 12,407 | 9,236 | 8,990 | 7,090 |
| TOTAL | $62,228 | $83,689 | $64,187 | $65,463 | $69,015 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,877 | N/A | 14,978 | 14,842 | 14,713 |
| Other Non-Current Liabilities | 17,274 | 14,397 | 19,231 | 20,416 | 13,378 |
| TOTAL | $28,151 | $14,397 | $34,209 | $35,258 | $28,091 |
| Total Liabilities | $90,379 | $98,086 | $98,396 | $100,721 | $97,106 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,149 | 5,568 | 5,568 | 5,567 | 5,530 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -319,973 | -315,356 | -312,469 | -312,249 | -304,129 |
| TOTAL | $27,716 | $30,777 | $32,853 | $32,167 | $39,357 |
| Total Liabilities And Equity | $118,095 | $128,863 | $131,249 | $132,888 | $136,463 |